Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PABPC1P7 is a pseudogene of the poly(A) binding protein cytoplasmic 1 (PABPC1) family in humans[1][4][5][7]. Pseudogenes are segments of DNA that resemble functional genes but are considered non-functional due to accumulated mutations, lack of transcription, or inability to encode a functional protein. PABPC1P7 does not encode an active protein product and does not appear to play a direct biological or pathological role. It is not considered a drug target, biomarker, or functionally relevant gene in current biomedical literature. The genuine PABPC1 gene encodes a cytoplasmic poly(A) binding protein involved in mRNA stabilization, transport, and translation[3][9]. However, PABPC1P7, as a pseudogene, does not encode this protein or take part in mRNA metabolism. There are no known disease associations, biological functions, or clinical implications for PABPC1P7, and it has no established role as a therapeutic target or drug interaction site[2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(A) binding protein, cytoplasmic 1 pseudogene 7 (PABPC1P7).